Extramammary Paget's disease resistant to surgery and imiquimod monotherapy but responsive to imiquimod combination topical chemotherapy with 5-fluorouracil and retinoic acid: A case report

Cutis

Volumn 77, Issue 4, 2006, Pages 245-250

  Ye, Jian Nan ^a,b,f   Rhew, David C ^d,e   Yip, Felix ^a,b   Edelstein, Leon ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Garfield Medical Center   (United States)

^c California Age Research Institute   (United States)

^d Zynx Health   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT; FLUOROURACIL; IMIQUIMOD; RETINOIC ACID;

AGED; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; MALE GENITAL TRACT TUMOR; PAGET SKIN DISEASE; PATHOLOGY;

ADMINISTRATION, CUTANEOUS; AGED; AMINOQUINOLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DIAGNOSIS, DIFFERENTIAL; FLUOROURACIL; GENITAL NEOPLASMS, MALE; HUMANS; MALE; PAGET'S DISEASE, EXTRAMAMMARY; TRETINOIN;

EID: 33646539490     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Zollo JD, Zeitouni NC. The Roswell Park Cancer Institute experience with extramammary Paget's disease. Br J Dermatol. 2000;142:59-65.
2. Coldiron BM, Goldsmith BA, Robinson JK. Surgical treatment of extramammary Paget's disease. a report of six cases and a reexamination of Mohs micrographic surgery compared with conventional surgical excision. Cancer. 1991;67:933-938.
3. Sauder DN. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol. 2000;43(1 pt 2): S6-S11.
4. Sidky YA, Borden EC, Weeks CE, et al. Inhibition of murine tumor growth by an interferon-inducing imidazoquinolineamine. Cancer Res. 1992;52:3528-3533.
5. Steinmann A, Funk Jo, Schuler G, et al. Topical imiquimod treatment of a cutaneous melanoma metastasis. J Am Acad Dermatol. 2000;43:555-556.
6. Zampogna JC, Flowers FP, Roth WI, et al. Treatment of primary limited cutaneous extramammary Paget's disease with topical imiquimod monotherapy: two case reports. J Am Acad Dermatol. 2002;47(suppl 4):S225-S235.
7. Qian Z, Zeitoun NC, Shieh S, et al. Successful treatment of extramammary Paget's disease with imiquimod. J Drugs Dermatol. 2003;2:73-76.
8. Wang LC, Blanchard A, Judge DE, et al. Successful treatment of recurrent extramammary Paget's disease of the vulva with topical imiquimod 5% cream. J Am Acad Dermatol. 2003;49:769-772.
9. Berman B, Spencer J, Villa A, et al. Successful treatment of extramammary Paget's disease of the scrotum with imiquimod 5% cream. Clin Exp Dermatol. 2003;28 (suppl 1):36-38.
10. Voigt H, Bassermann R, Nathrath W. Cytoreductive combination chemotherapy for regionally advanced unresectable extramammary Paget's carcinoma. Cancer. 1992;70:704-708.
11. Bewley AP, Bracka A, Staughton RC, et al. Extramammary Paget's disease of the scrotum: treatment with topical 5-fluorouracil and plastic surgery. Br J Dermatol. 1994;131:445-446.
12. Kawatsu T, Miki Y. Triple extramammary Paget's disease. Arch Dermatol 1971;104:316-319.
13. Fetherston WC, Friedrich EG. The origin and significance of vulvar Paget's disease. Obstet Gynecol. 1972;39: 734-744.
14. Haberman HF, Goodall J, Llewellyn M. Extramammary Paget's disease. Can Med Assoc J. 1975;118:161-162.
15. Eliezri YD, Silvers DN, Horan DB. Role of preoperative topical 5-fluorouracil in preparation for Mohs micrographic surgery of extramammary Paget's disease. J Am Acad Dermatol. 1987;17:497-505.
16. Del Castillo LF, Garcia C, Schoendorff C, et al. Spontaneous apparent clinical resolution with histologic persistence of a case of extramammary Paget's disease: response to topical 5-fluorouricil. Cutis. 2000;65:331-333.
17. Hsu CA, Rishi AK, Su-Li X. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. Blood. 1997;89:4470-4479.
18. Meister B, Fink FM, Hittmair A, et al. Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma. Anticancer Res. 1998;18:1777-1786.